YY1 Is a Key Player in Melanoma Immunotherapy/Targeted Treatment Resistance

Dominika Kwiatkowska(University of Rzeszów), Adam Reich(Rzeszów University of Technology), Ewelina Mazur(University of Rzeszów)
Frontiers in Oncology
June 1, 2022
Cited by 40


Related Papers